If you think the threat of H1N1, SARS, Mad Cow or Salmonella is still out there, then you are going to love what happened the penny stock of Press Ventures, Inc. (PVEN). Having initiated coverage shortly after they effectuated a 50 for 1 stock split, the “it’s looking like CEO, Wilson A. Garduque, is soon to host an ask-slapping party that must be on the watch list” phrase was not taken lightly by some who were waiting patiently for PVEN stock to begin trading. After coming out with news pre-market that the Company secured the global sales and marketing rights to a patented all-natural essential oil disinfectant and diffusing system, the newly appointed CEO, Edward Denkiewicz, got to be the kick-off host for what’s looking like a touchdown play already.
Our Next Pick Is Coming Soon! Click HERE To Make Sure You Don’t Miss Any Of Our Breaking Alerts!
PVEN Stock Quote
Market Cap: 99.60M
Last: 0.24 ▲ +0.14 (140.00%)
Volume: 314,752
Dollar Volume: $58,734
Open: 0.15
High: 0.24
Low: 0.15
Trades: 59
Authorized: 5 Billion
Issued and Outstanding: 315,000,000
Edward Denkiewicz: 170,000,000
1st Resistance Point: 0.27
1st Support Level: 0.18
Looking for Hot Penny Stocks?
Click here To Receive FREE Penny Stock Alerts
Two weeks ago, Press Ventures made the inaugural move of entering into a Management Consulting Agreement with Edward Denkiewicz and appointed him as the Company’s President, CEO, CFO, Secretary and Treasurer; aka the Sole Director. Denkiewicz is set to score a whopping $2,000 a month on top of his $5,000 one-time signing bonus while Wilson A. Garduque gets to chill out now that PVEN has something to run on.
Believing that, at any moment, virus outbreaks and food bacteria deaths could erupt, growth in the services sterilization market is where Biosaftey Systems is going to attempt to capitalize on. It’s a sexy story, one that could see some insane interest in if the awareness campaign is handled correctly by the Company’s IR firm, Kingston Communications.
Really, all they would need to do, is to focus on the hypochondriac mentality of investors with their note of the market opportunity. From the 8-K filing:
In a survey of 100 U.S. office buildings, 23 percent of office workers experienced frequent symptoms of Sick Building Syndrome (SBS) such as respiratory ailments, allergies and asthma. The impact of these symptoms results in sick days, lower productivity and medical costs, and the economic impact is large, with an estimated decrease in productivity around 2 percent nationwide, resulting in an annual cost to the United States of approximately $60 billion.
A potential $60 billion market with 145 million shares of PVEN to go around – it’s reminiscent of quote from the 90’s movie Boiler Room: “The rip on FARO TECH is now $3 dollars!!!!!”
Looking forward to what should be the first big penny stock promotion heading into September, a glance at what happened prior to the deal with Biosaftey Systems is prudent.
During the year ended October 31, 2010, Press Ventures issued 275,000,000 shares of PVEN stock for total proceeds of $22,000. During the 9 months ended July 31, 2012, another 140,000,000 shares were issued for total proceeds of $28,000. According to the SC 13D filing from Monday, BioSafety Systems Sp. z o.o. is the beneficial owner of 170,000,000 shares and 100,000,000 shares appear to have been canceled since the 10-Q filing.
In summary, 5 million of the original 275 million that were originally held by Caroline Johnston, transferred to Lynda Cambly, transferred then to Wilson A. Garduque are still out there with a cost basis of $0.00008 and the 140 million issued for $28,000, cost basis of $0.0002, are now 0.24. Translation: PVEN is a money making machine.
About PVEN Stock
Press Ventures, Inc., through their Technology License Agreement with BioSafety Systems Sp. Z o.o., a limited liability company organized under the laws of Poland, is a development stage company which has acquired the rights to an all-natural patented essential oil disinfectant system that combats infection from molds, fungus, and airborne viruses.
Click here to view the SEC filings for PVEN.
Click here to view the website for Biosaftey Systems.
Last 5 Trading Sessions:
Date | Last | Change | Volume | |
08/26/13 | 0.2400 | +0.1400 | +140.00% | 314,700 |
07/10/13 | 0.1000 | unch | unch | 14,900 |
07/02/13 | 0.1000 | unch | unch | 500 |
06/19/13 | 0.1000 | unch | unch | 5,000 |
06/04/13 | 0.1000 | unch | unch | 100 |
Bottom Line:
The ask-slapping party has begun and not having PVEN on your list of penny stocks to watch might having you chasing a climbing PPS. The share structure is so much like other big-money promotions that Awesome Penny Stocks have used before that it’s not funny. Since PVEN stock has already begun trading and no teasers have come out from APS or their affiliates at Victory Mark, it’s good news in a sense that this night not be their next pump to follow Xumanii (XUII).
Our Next Pick Is Coming Soon! Text Keyword “AIMHIGH” To 99000 To Make Sure You Don’t Miss It!
ShareAUG